Abstract
AbstractSpontaneous protein crystallization is a rare event, yet protein crystals are frequently found in eosinophil-rich inflammation. In humans, Charcot-Leyden crystals (CLCs) are made from galectin-10 (Gal10) protein, an abundant protein in eosinophils. Whereas mice do not encode Gal10 in their genome, they do form pseudo-CLCs, made from the chitinase-like proteins Ym1 and/or Ym2, encoded byChil3andChil4and made by myeloid and epithelial cells respectively. Here, we investigated the biological effects of pseudo-CLCs since their function is currently unknown. We produced recombinant Ym1 crystals which were shown to have identical crystal packing and structure by X-ray crystallography asin vivonative crystals derived from murine lung. When administered to the airways of mice, crystalline but not soluble Ym1 stimulated innate and adaptive immunity and acted as a type 2 immune adjuvant for eosinophilic inflammation via triggering of dendritic cells (DCs). Murine Ym1 protein crystals found at sites of eosinophilic inflammation reinforce type 2 immunity and could serve as a surrogate model for studying the biology of human CLCs.
Publisher
Cold Spring Harbor Laboratory
Reference54 articles.
1. Charcot, J. & Vulpian, A. Note sur des cristaux particuliers trouvés dans le sang et dans certains viscèresd’un sujet leucémique, et sur d’autres faits necroscopiques observés sur le même sujet. Gaz. Hebd. de Méd et Chirurgie, 755–758 (1860).
2. Zur Kenntniss des Bronchial-Asthma
3. Charcot-Leyden crystals and other protein crystals driving type 2 immunity and allergy;Curr Opin Immunol,2021
4. Inhibition of protein crystallization by evolutionary negative design
5. Protein crystallization in living cells